-
Booking Health Announces Expanded Access to Stage 4 Lung Cancer Treatments During Lung Cancer Awareness Month
10 Nov 2025 15:27 GMT
… only available systemic treatment for metastatic lung cancer. This approach uses cytotoxic … to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, … valuable for small, well-defined lung tumors or oligometastatic disease. This …
-
Yuhan, Janssen Korea to jointly promote Leclaza+Rybrevant combo for EGFR-mutated lung cancer
10 Nov 2025 06:15 GMT
… with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR … EGFR-mutated non-small cell lung cancer,” Yuhan CEO Cho Wook-je …
-
Gilead announces phase 3 ASCENT─07 study of Trodelvy versus chemotherapy to treat post─endocrine therapy in HR+/HER2─negative metastatic breast cancer fails to meet the primary endpoint of PFS
10 Nov 2025 07:59 GMT
… all patients with metastatic disease eventually progress and … 90% of breast and lung cancers. Trodelvy is intentionally … Unresectable locally advanced or metastatic triple-negative breast cancer ( … systemic therapies in the metastatic setting.
Gilead and …
-
'I was in incredible pain... the doctor said it was just discomfort from breastfeeding': Gini was a non-smoker whose bad shoulder left her in agony. Eventually, she discovered it was lung cancer. Now, our expert reveals the hidden signs of the …
08 Nov 2025 20:27 GMT
… you would traditionally associate with lung cancer, I didn’t have … . Worse still, Gini’s lung cancer did not respond to standard … , like Gini, don’t get lung cancer.
‘This rise in cases – … specialist, the cancer has metastasised and our options are limited …
-
Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS® in HER2 lung cancer
08 Nov 2025 02:35 GMT
… non-small cell lung cancer (NSCLC)
Lung cancer claims more lives … patients with metastatic non-small cell lung cancer receiving chemotherapy … Symptoms in Newly Diagnosed Lung Cancer. Health Psychol. 2022 … -hernexeos-in-her2-lung-cancer-302609119.html
SOURCE …
-
<![CDATA[Top Lung Cancer Stories from October: Insights, and Patient Journeys ]]>
07 Nov 2025 04:17 GMT
… , noting that patients with liver metastases, as well as those with … , pathologically confirmed locally advanced or metastatic nonsquamous NSCLC harboring EGFR exon … ;view/lung-cancer-basics-for-newly-diagnosed-patients
“How Lung Cancer Helped to …
-
<![CDATA[Amtagvi Prompts Responses in Non–Small Cell Lung Cancer]]>
06 Nov 2025 20:31 GMT
… non-squamous non-small cell lung cancer without actionable genetic mutations, new … non-squamous non-small cell lung cancer and a potential launch in … -in-its-class approval [for] metastatic melanoma, where we’re using …
-
Antibody-Drug Conjugate Shows Clinical Benefit Against Small-Cell Lung Cancer
06 Nov 2025 19:08 GMT
… with extensive-stage small cell lung cancer (ES-SCLC) according … about 12% of all lung cancer cases in the United … extensive-stage small cell lung cancer still experience relapse after … patients with asymptomatic brain metastasis responded to treatment better …
-
CMTR2 Mutation in Lung Cancer Reveals Therapy Targets
06 Nov 2025 15:00 GMT
… control, apoptosis, and metastatic potential. The aberrant splicing … lung cancercomprehensive genomic analysis in oncologygenetic heterogeneity in lung cancerlung … adenocarcinoma therapy targetsmolecular mechanisms of lung cancermRNA cap …
-
Patients with Advanced Non-Small Cell Lung Cancer and the EGFR Exon 19 Deletion p.L747 Benefit from Chemotherapy and First-Generation Tyrosine Kinase Inhibitors Compared with Patients with p.E746
06 Nov 2025 14:10 GMT
… kinase inhibitor in metastatic non-small-cell lung cancer. J Thorac … mutant non-small cell lung cancer. Lung Cancer. 2014;86(2):213 … in non-small cell lung cancer. Transl Lung Cancer Res. 2020;9 … advanced non-small-cell lung cancer. Lung Cancer. 2022;166:9–16 …
About
© 1995-2025